Precision immunotherapy
for hard-to-treat cancers

At Imuno we develop highly specific immunotherapies against an untapped universe of cancer antigens. We continue to build a growing pipeline of precision immunotherapies against novel antigens in multiple indications.

With Imuno TACTICSTM we engineer antibodies that bind antigens presented by MHC molecules with high specificity. This allows us to develop potent therapies while leaving healthy tissues unharmed.

We have built a promising pipeline and are supporting our partners in selecting therapeutic candidates with the right specificity profile.